京新药业：LP（a）机制降脂新药的对外授权工作进展中，公司会努力推进

Group 1 - The company is currently in the process of negotiating external licensing for its innovative lipid-lowering drug, specifically the LP(a) mechanism [2] - The company is committed to advancing the licensing work and will provide updates through relevant announcements as progress is made [2]